tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Avidity Biosciences Completes Merger and Plans Nasdaq Delisting
PremiumCompany AnnouncementsAvidity Biosciences Completes Merger and Plans Nasdaq Delisting
14d ago
Atrium Therapeutics launches as newly independent, publicly traded company
Premium
The Fly
Atrium Therapeutics launches as newly independent, publicly traded company
14d ago
Novartis completes acquisition of Avidity Biosciences
Premium
The Fly
Novartis completes acquisition of Avidity Biosciences
14d ago
Avidity Plans Spin-Off Amid Novartis Acquisition Agreement
PremiumCompany AnnouncementsAvidity Plans Spin-Off Amid Novartis Acquisition Agreement
1M ago
Avidity Biosciences announces expected record date for spin-off
Premium
The Fly
Avidity Biosciences announces expected record date for spin-off
1M ago
Avidity Biosciences Sets February Vote on $72-per-Share Novartis Takeover and Cardiology Spin-Off
Premium
Company Announcements
Avidity Biosciences Sets February Vote on $72-per-Share Novartis Takeover and Cardiology Spin-Off
1M ago
Hold Rating on Avidity Biosciences Amid Novartis Acquisition Uncertainty
PremiumRatingsHold Rating on Avidity Biosciences Amid Novartis Acquisition Uncertainty
4M ago
Avidity Biosciences Reports Increased Revenue Amid Losses
Premium
Company Announcements
Avidity Biosciences Reports Increased Revenue Amid Losses
4M ago
Avidity Biosciences reports Q3 EPS ($1.27), consensus ($1.10)
Premium
The Fly
Avidity Biosciences reports Q3 EPS ($1.27), consensus ($1.10)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100